HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

5th Edition of

International Ophthalmology Conference

Stargardt Disease

Stargardt Disease

Stargardt disease, also referred to as Stargardt macular dystrophy or juvenile macular degeneration, is a genetic eye condition impacting the macula—the part of the retina essential for sharp central vision. Typically emerging in childhood or adolescence, this disorder results in gradual loss of central vision. It stems from mutations in the ABCA4 gene, causing the accumulation of lipofuscin deposits in retinal pigment epithelium cells.

Affected individuals may experience challenges such as blurred vision, difficulty reading, and reduced visual acuity in low light conditions. While currently without a cure, ongoing research strives to deepen our understanding and explore potential therapeutic avenues. Management often involves visual aids like magnifying lenses and adjustments in daily routines to accommodate central vision impairment. Genetic counseling plays a pivotal role in assisting affected individuals and families due to the hereditary nature of Stargardt disease.

Committee Members

Speaker at IOC 2027 - Anna Maria Bassi

Anna Maria Bassi

University of Genoa, Italy
Speaker at IOC 2027 - Magali Taiel

Magali Taiel

GenSight Biologics, France
Speaker at IOC 2027 - Pierdomenico D Andrea

Pierdomenico D Andrea

University “G. D’Annunzio, Italy

IOC 2027 Speakers

Speaker at IOC 2027 - Abdullah Shakeel

Abdullah Shakeel

Princess Alexandra Hospital NHS Trust, United Kingdom
Speaker at IOC 2027 - S’ad Shaikh

S’ad Shaikh

Princess Alexandra Hospital NHS Trust, United Kingdom
Speaker at IOC 2027 - Shenika Tailor

Shenika Tailor

University Hospitals of Leicester NHS Trust, United Kingdom
Speaker at IOC 2027 - Zamin Shabir

Zamin Shabir

Princess Alexandra Hospital NHS Trust, United Kingdom

Submit your abstract Today

YouTube
WhatsAppWhatsApp